Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation - insights from acute and chronic electroanatomic remapping in the randomized SINGLE-SHOT CHAMPION trial [0.03%]
导管消融治疗阵发性房颤：随机对照的SINGLE-SHOT CHAMPION研究中急性与慢性心电解剖重构的启示
Thomas Kueffer,Sven Knecht,Elias Ayadi et al.
Thomas Kueffer et al.
Background and aims: The SINGLE SHOT CHAMPION multicenter trial compared the effectiveness of pulsed-field ablation (PFA) and cryoballoon ablation (CBA) for pulmonary vein isolation (PVI) in patients with paroxysmal atria...
Pulmonary vein reconnection patterns after pentaspline pulsed field ablation for atrial fibrillation [0.03%]
用于房颤治疗的五重样条脉冲场消融后的肺静脉再连接模式
Alexander Lucius,Stephan Kische,Stefan Mueller
Alexander Lucius
Angioplasty for Pulmonary Vein Stenosis after Atrial Fibrillation Ablation [0.03%]
肺静脉狭窄的球囊成形术治疗术后并发症房颤导管消融后的肺静脉狭窄的球囊成形术治療
André Fitzner,Martin Martinek,Helmut Pürerfellner et al.
André Fitzner et al.
Compliance to direct oral anticoagulation therapy and clinical outcomes after catheter ablation for atrial fibrillation: a nationwide cohort study [0.03%]
中国射频消融术后房颤直接口服抗凝血药物依从性及临床疗效的全国队列研究
Bjarke Sihm Stender,Victor Kjær Eskildsen,Anders Kramer et al.
Bjarke Sihm Stender et al.
Background and aims: Life-long direct oral anticoagulant (DOAC) therapy is recommended after catheter ablation for atrial fibrillation (AF) in high-risk patients (CHA2DS2-VA≥2). Long-term DOAC compliance is crucial for e...
Atrial cardiomyopathy as a multidomain disease: longitudinal evidence for autonomic remodelling [0.03%]
房室心肌病作为多域疾病：自主神经重塑的纵向证据
Jean-Baptiste Guichard,David Hupin,Vincent Pichot et al.
Jean-Baptiste Guichard et al.
Aims: Atrial cardiomyopathy (AtCM) is increasingly recognized as a substrate for atrial fibrillation (AF), yet its operationalization remains limited and largely marker-driven. Whether autonomic remodelling represents a l...
Impact of a balloon-in-basket pulsed field ablation catheter on oesophageal temperature changes during pulmonary vein isolation [0.03%]
一种气球固定脉冲电场消融导管对肺静脉隔离时食道温度变化的影响研究
Julia Vogler,Roman Mamaev,Jan-Per Wenzel et al.
Julia Vogler et al.
Catheter ablation of atrial fibrillation in transthyretin and light-chain cardiac amyloidosis: results from the multicentre AMYL-AF study [0.03%]
转甲状腺素蛋白和轻链心脏淀粉样变房颤导管消融的疗效：一项多中心研究结果分析
Daniele Faccenda,Marco Bergonti,Tom De Potter et al.
Daniele Faccenda et al.
Aims: Atrial fibrillation (AF) is highly prevalent among cardiac amyloidosis (CA) patients and contributes significantly to their morbidity and mortality. Evidence regarding AF ablation efficacy and safety in CA patients ...
Male predominance in sports sudden cardiac arrest: a behavioural driver of risk? [0.03%]
运动性突发心脏事件中男女性别差异的行为学驱动因素？
Richard Chocron,Xavier Jouven
Richard Chocron
Graphical Abstract
Early catheter ablation vs. antiarrhythmic drugs in treatment-naïve ischaemic ventricular tachyarrhythmias: a meta-analysis of randomized controlled trials [0.03%]
首次治疗的缺血性室性心律失常患者导管消融与抗心律失常药物对比：系统评价和Meta分析
Tiago Moura Façanha,Anna Isabelle Gomes Pereira,Maria Fernanda Carvalho Garcia et al.
Tiago Moura Façanha et al.
Introduction: Antiarrhythmic drugs (AADs) have traditionally been used as first-line therapy for ventricular tachycardia (VT) but are frequently associated with systemic toxicities and drug interactions. Therefore, we per...
Interrater agreement in atrial fibrillation diagnosis using one-week single-lead patch ECG monitoring: Findings from the NORSCREEN trial [0.03%]
来自NORSCEEG试验中使用单导联贴片心电图监测一周的诊断一致性：房颤患者的发现
Marius B Haraldsen,Miroslav Boskovic,Trygve Berge et al.
Marius B Haraldsen et al.